Please ensure Javascript is enabled for purposes of website accessibility

FDA Asks to Extend E-Cig Application Deadline Until September

By Rich Duprey - Apr 6, 2020 at 1:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The agency recognizes that the coronavirus pandemic may make it harder for companies to complete their applications on schedule.

The Food and Drug Administration is seeking a 120-day extension of the deadline by which electronic cigarette manufacturers need to submit their premarket tobacco product applications. 

The current May 12 deadline was imposed after a U.S. district court judge ruled the agency had shirked its responsibility by allowing e-cigs to be marketed without regulatory oversight. However, because of the "highly unusual circumstances" brought on by the coronavirus pandemic, the FDA believes the extension is warranted.

The regulator submitted its request to the same Maryland district court that originally demanded that the FDA take action. If granted, the extension would move the deadline to Sept. 9.

Many using a vaping device

Image source: Getty Images.

E-cigarette manufacturers, including companies that make the e-liquids used in the devices, as well as cigars and other nicotine and tobacco products, need to submit applications to the FDA for review if they want to keep selling their products in the U.S.

So far only Philip Morris International (PM -0.23%) and British American Tobacco (BTI -0.03%) have submitted applications, and only Philip Morris' IQOS device has been approved.

There are questions about how many companies other than the industry giants will be able to comply with these regulations, as the applications for the two tobacco companies have run into the tens of thousands of pages and cost them millions of dollars to complete. It took the FDA over two years to approve Philip Morris's application; British American Tobacco's, which was submitted late last year, is still under review.

 

Rich Duprey has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Philip Morris International Inc. Stock Quote
Philip Morris International Inc.
PM
$99.24 (-0.23%) $0.23
British American Tobacco p.l.c. Stock Quote
British American Tobacco p.l.c.
BTI
$40.42 (-0.03%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
389%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.